22
Oct
2025
PExA files patent application for biomarkers enabling early detection of lung cancer
PExA AB (Spotlight: PEXA) announces that the company has filed a patent application covering protein patterns for the early detection of lung cancer, based on its proprietary non-invasive airway sampling technology. Lung cancer remains the leading cause of cancer-related death worldwide, largely because the disease is typically diagnosed too late. Earlier detection could dramatically increase the chances of…
Read more